Presentation and Status in Health Basket
5 X 500 mg
Pneumonia: one tablet, one or two times a day.
Urinary tract infection: one tablet, once a day.
Infection of the skin or neighboring tissues, muscle infection: one tablet, one or two times a day.
Elderly patients or patients with kidney diseases: may prescribe a lower dosage.
Mild to moderate infections including acute sinusitis, acute exacerbation of chronic bronchitis, community acquired pneumonia, complicated urinary tract infections, skin and soft tissue infections.
Hypersensitivity to the drug, epilepsy, fluroquinolone related tendon disorders, pregnancy, lactation, children under 18 years old.
May not be the optimal therapy in the most severe cases of pneumococal pneumonia. Nosocomial infections due to P. aeruginosa may require combination therapy. Infusion time of at least 60 minutes should be observed. If pseudomembranous colitis is suspected, therapy must be stopped immediately and patients should be treated with supportive measures. Tendinitis, patients with a history of epilepsy, patients with G-6-phosphate dehydrogenase deficiency. The dose should be adjusted in patients with renal impairment. Patients should not expose themselves unnecessarily to strong sunlight or to artificial UV rays.
Pruritus, rash, nausea, diarrhea, anorexia, vomiting, abdominal pain, dyspepsia, headache, dizziness/vertigo, drowsiness, insomnia, increased liver enzyme levels (e.g. ALT, AST), increase in bilirubin, increase in serum creatinine, pain, reddening of the infusion site and phlebitis, acute confusional states and depressive mood changes, extrapyramidal symptoms, attacks of porphyria in patients with porphyria.
See prescribing information for full details.